<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xhtml="http://www.w3.org/1999/xhtml" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.w3.org/1999/xhtml http://www.w3.org/2002/08/xhtml/xhtml1-strict.xsd">
<url>
<loc>https://www.cslbehring.no/</loc>
<priority>1.0000</priority>
<lastmod>2025-10-20</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/hope-in-new-year</loc>
<priority>0.5000</priority>
<lastmod>2023-11-02</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/om-csl-behring</loc>
<priority>0.5000</priority>
<lastmod>2025-04-10</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/global-selector</loc>
<priority>0.5000</priority>
<lastmod>2023-10-26</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter</loc>
<priority>0.5000</priority>
<lastmod>2025-03-06</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/forskning-and-utvikling</loc>
<priority>0.5000</priority>
<lastmod>2024-01-08</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/produkter</loc>
<priority>0.5000</priority>
<lastmod>2024-06-14</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell</loc>
<priority>0.5000</priority>
<lastmod>2025-04-14</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/nordiske-nyheter</loc>
<priority>0.5000</priority>
<lastmod>2025-07-28</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/kontakt</loc>
<priority>0.5000</priority>
<lastmod>2024-01-08</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/nordiske-land</loc>
<priority>0.5000</priority>
<lastmod>2025-07-28</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/bruksvilkar</loc>
<priority>0.5000</priority>
<lastmod>2020-05-18</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/bivirkningsrapportering</loc>
<priority>0.5000</priority>
<lastmod>2025-05-13</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/sideoversikt</loc>
<priority>0.5000</priority>
<lastmod>2023-11-02</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/search</loc>
<priority>0.5000</priority>
<lastmod>2023-11-02</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/retningslinjer-for-informasjonskapsler</loc>
<priority>0.5000</priority>
<lastmod>2023-11-06</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/tilgjengelighetserklaering</loc>
<priority>0.5000</priority>
<lastmod>2023-11-02</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/play</loc>
<priority>0.5000</priority>
<lastmod>2025-04-14</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/om-csl-behring/var-ledergruppe</loc>
<priority>0.5000</priority>
<lastmod>2025-05-14</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/om-csl-behring/efpia-disclosure-code</loc>
<priority>0.5000</priority>
<lastmod>2023-08-28</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/om-csl-behring/karriere</loc>
<priority>0.5000</priority>
<lastmod>2026-01-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon</loc>
<priority>0.5000</priority>
<lastmod>2024-01-08</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/a1rtime</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/immunsvikt-og-autoimmune-sykdommer</loc>
<priority>0.5000</priority>
<lastmod>2025-05-14</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/arvelige-blodningsforstyrrelser</loc>
<priority>0.5000</priority>
<lastmod>2025-05-14</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/hereditaert-angioodem-hae</loc>
<priority>0.5000</priority>
<lastmod>2025-03-12</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/alfa-1-antitrypsinmangel</loc>
<priority>0.5000</priority>
<lastmod>2024-11-04</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/immunsvikt-og-autoimmune-sykdommer/primaer-immunsvikt</loc>
<priority>0.5000</priority>
<lastmod>2025-07-28</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/immunsvikt-og-autoimmune-sykdommer/sekunaer-immunsvikt</loc>
<priority>0.5000</priority>
<lastmod>2025-07-28</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/immunsvikt-og-autoimmune-sykdommer/cidp</loc>
<priority>0.5000</priority>
<lastmod>2025-05-14</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/immunsvikt-og-autoimmune-sykdommer/itp</loc>
<priority>0.5000</priority>
<lastmod>2025-05-14</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/immunsvikt-og-autoimmune-sykdommer/gbs</loc>
<priority>0.5000</priority>
<lastmod>2025-05-14</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/immunsvikt-og-autoimmune-sykdommer/kawasaki</loc>
<priority>0.5000</priority>
<lastmod>2025-05-15</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/immunsvikt-og-autoimmune-sykdommer/mmn</loc>
<priority>0.5000</priority>
<lastmod>2025-05-15</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/arvelige-blodningsforstyrrelser/vws</loc>
<priority>0.5000</priority>
<lastmod>2025-07-28</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/arvelige-blodningsforstyrrelser/hemofili-a</loc>
<priority>0.5000</priority>
<lastmod>2025-07-28</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/arvelige-blodningsforstyrrelser/hemofili-b</loc>
<priority>0.5000</priority>
<lastmod>2025-07-28</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/arvelige-blodningsforstyrrelser/faktor-x</loc>
<priority>0.5000</priority>
<lastmod>2025-06-16</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/arvelige-blodningsforstyrrelser/faktor-xiii</loc>
<priority>0.5000</priority>
<lastmod>2025-07-28</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/arvelige-blodningsforstyrrelser/fibrinogenmangel</loc>
<priority>0.5000</priority>
<lastmod>2025-07-28</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/arvelige-blodningsforstyrrelser/kvinner-med-blodersykdom</loc>
<priority>0.5000</priority>
<lastmod>2025-03-27</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/arvelige-blodningsforstyrrelser/kvinner-med-blodersykdom/nordisk-studie-om-kvinner-med-blodersykdom</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/hereditaert-angioodem-hae/hva-er-hae</loc>
<priority>0.5000</priority>
<lastmod>2026-01-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/hereditaert-angioodem-hae/hvordan-pavirker-hae-livet-ditt</loc>
<priority>0.5000</priority>
<lastmod>2026-01-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/hereditaert-angioodem-hae/behandling-av-hae</loc>
<priority>0.5000</priority>
<lastmod>2026-02-04</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/hereditaert-angioodem-hae/a-leve-med-hae</loc>
<priority>0.5000</priority>
<lastmod>2026-01-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/sykdomsinformasjon/hereditaert-angioodem-hae/rad-til-foreldre-med-barn-som-har-hae</loc>
<priority>0.5000</priority>
<lastmod>2026-01-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/a1rtime/when-should-you-test-for-alpha-1-antitrypsin-deficiency</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/a1rtime/the-physically-active-non-smoker-can-also-have-an-alpha-1-antitrypsin-deficiency</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/a1rtime/videocast-helene-are-you-ill-or-just-a-carrier-of-alpha-1</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/a1rtime/karen-went-to-germany-and-was-given-10-extra-years</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/a1rtime/bounced-between-different-hospitals</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/a1rtime/early-diagnosis-offers-better-treatment-options</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/a1rtime/the-complete-fascination-of-a-protein</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/pasienter/a1rtime/the-long-road-to-diagnosis</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/produktliste</loc>
<priority>0.5000</priority>
<lastmod>2024-06-14</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/play</loc>
<priority>0.5000</priority>
<lastmod>2025-10-10</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/bestill-materiale</loc>
<priority>0.5000</priority>
<lastmod>2024-08-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader/immunologi-nevrologi</loc>
<priority>0.5000</priority>
<lastmod>2024-10-28</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader/hematologi</loc>
<priority>0.5000</priority>
<lastmod>2025-10-10</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader/alfa-1-antitrypsinmangel</loc>
<priority>0.5000</priority>
<lastmod>2024-11-04</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader/hereditaert-angioodem</loc>
<priority>0.5000</priority>
<lastmod>2025-04-10</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader/hereditaert-angioodem/what-is-hae</loc>
<priority>0.5000</priority>
<lastmod>2026-01-29</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader/hereditaert-angioodem/the-burden-of-hae</loc>
<priority>0.5000</priority>
<lastmod>2026-01-29</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader/hereditaert-angioodem/goals-of-hae-treatment-and-available-treatment-options</loc>
<priority>0.5000</priority>
<lastmod>2026-01-30</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader/hereditaert-angioodem/considerations-for-special-patient-populations</loc>
<priority>0.5000</priority>
<lastmod>2026-01-29</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader/hereditaert-angioodem/invitation-a-csl-sponsored-webinar</loc>
<priority>0.5000</priority>
<lastmod>2025-10-20</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader/hereditaert-angioodem/invitation-a-csl-sponsored-webinar/notification-form</loc>
<priority>0.5000</priority>
<lastmod>2025-11-12</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/vores-terapiomrader/hereditaert-angioodem/invitation-a-csl-sponsored-webinar/notification-form/thank-you</loc>
<priority>0.5000</priority>
<lastmod>2025-11-12</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/produktliste/hemgenix/opplaeringsmateriell</loc>
<priority>0.5000</priority>
<lastmod>2023-10-31</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/pamelding-till-nyheter/danke</loc>
<priority>0.5000</priority>
<lastmod>2024-02-01</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/pamelding-till-nyheter/error</loc>
<priority>0.5000</priority>
<lastmod>2024-02-01</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/online-webinars/webinar-esid-2020</loc>
<priority>0.5000</priority>
<lastmod>2023-10-27</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/factsforu-helsepersonell/online-webinars/webinar-hae-management-2021</loc>
<priority>0.5000</priority>
<lastmod>2023-10-27</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/nordiske-nyheter/2017</loc>
<priority>0.5000</priority>
<lastmod>2020-05-18</lastmod>
</url>
<url>
<loc>https://www.cslbehring.no/nordiske-nyheter/2018</loc>
<priority>0.5000</priority>
<lastmod>2020-05-18</lastmod>
</url>
</urlset>
